Description:

ODM derived from http://clinicaltrials.gov/show/NCT00505388

Link:

http://clinicaltrials.gov/show/NCT00505388

Keywords:
Versions (2) ▾
  1. 12/10/13
  2. 4/14/14
Uploaded on:

April 14, 2014

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00505388 Bronchial Asthma

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Age at least 18 years
Asthma patients prescribed Symbicort as maintenance and reliever therapy, according to the label, before inclusion in this programme
signed and dated informed consent(ICF)
for patients under-age, signed and dated ICF form from both the patient and the patient's parent/legal guardian is required
Exclusion Criteria
Involvement in the planning and conduct of the programme (applies to both AstraZeneca staff or staff at the investigational site)